MAPT and Alzheimer disease: Recent studies have demonstrated that greater BAG is associated with greater amyloid PET burden in a Down syndrome cohort (Cole et al., 2017a) and with greater tau PET burden in sporadic MCI and symptomatic AD (Lee et al., 2022).